Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent influenza split virion vaccine 7.5 μg vs trivalent influenza split vaccine in 6–35‑month‑old children
CTR20191427Phase 3Completed
- Sponsor
- Hualan Biological Vaccine
- Start
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine (split virion, inactivated, quadrivalent) in influenza, sponsored by Hualan Biological Vaccine. Started Jul 2019; status: completed.
02
Drugs
influenza vaccine (split virion, inactivated, quadrivalent)
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20191427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191427.